The cardiac endothelin system in established pressure overload left ventricular hypertrophy

被引:25
|
作者
Schunkert, H [1 ]
Orzechowski, HD
Böcker, W
Meier, R
Riegger, GAJ
Paul, M
机构
[1] Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany
[2] Free Univ Berlin, Inst Clin Pharmacol & Toxicol, Benjamin Franklin Med Ctr, Berlin, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 08期
关键词
cardiac hypertrophy; endothelin; endothelin converting enzyme; endothelin receptor;
D O I
10.1007/s001099900035
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In normal hearts, endothelin-1 (ET-1) has been shown to initiate myocyte growth and to modulate cardiac function. However, regulation of the various components of the system and the functional effects of ET-1 in established left ventricular hypertrophy (LVH) are less clear. We thus studied ET-1, ETA receptor, and endothelin converting enzyme (ECE-1) mRNA regulation as well as the effects of ET-1 on coronary resistance, LV contractility and relaxation in hypertrophied rat hearts. Cardiac pressure overload, secondary to banding of the ascending aorta, resulted in a transient increase of cardiac ET-1 and ETA receptor mRNAs that reached a maximum at 2 days (+75% and +40%, respectively, P<0.05, each). ET-1 mRNA levels reached a second peak at 84 days of pressure overload (+60%, P<0.05), at the later time point in conjunction with elevated ECE-1 mRNA levels (+20%, P<0.05). The functional implications of ET-1 were examined in a study of isolated perfused hearts. Both hearts with established LVH and sham control hearts responded to ET-1 perfusion (10-(11) to 10(-9) M) with an increase of coronary perfusion pressure (CPP; +85+/-15 and +75+/-8 mmHg; P<0.001 each) and a slight decrease of LV systolic pressure (LVP; -12+/-9 and -9+/-7 mmHg; P=NS). In contrast, ET-1 increased LV end-diastolic pressure (LVEDP) only in LVH hearts (+22+/-7 mmHg, P<0.05 versus baseline and +20 +/-7 mmHg, P<0.05 versus sham). Direct stimulation of protein kinase C mimicked the effects of ET-1, whereas inhibition of this kinase or the Na+-H+ exchanger blunted the effects of ET-1 on CPP, LVP, and LVEDP. Interestingly, coadministration of the vasodilator and the nitric oxide (NO) donor nitroglycerin not only prevented the increase of CPP and LVEDP, but also uncovered a slight positive inotropic effect of ET-1 in LVH hearts. Thus, the cardiac expression of ET-1, ETA, and ECE-1 mRNAs displays a distinct pattern during early and advanced cardiac pressure overload. Furthermore, ET-1 mediates a slight depression of systolic, and a profound depression of diastolic, functional parameters in hearts with established LVH, effects that appear to be secondary to ET-1-related coronary vasoconstriction. The data suggest a functional role of the endothelin system in hearts with established pressure overload hypertrophy.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 50 条
  • [1] The cardiac endothelin system in established pressure overload left ventricular hypertrophy
    Heribert Schunkert
    Hans-Dieter Orzechowski
    Wolfgang Böcker
    Reinhard Meier
    Günter A.J. Riegger
    Martin Paul
    Journal of Molecular Medicine, 1999, 77 : 623 - 630
  • [2] Nifedipine Inhibits Cardiac Hypertrophy and Left Ventricular Dysfunction in Response to Pressure Overload
    Ago, Tetsuro
    Yang, Yanfei
    Zhai, Peiyong
    Sadoshima, Junichi
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (04) : 304 - 313
  • [3] Nifedipine Inhibits Cardiac Hypertrophy and Left Ventricular Dysfunction in Response to Pressure Overload
    Tetsuro Ago
    Yanfei Yang
    Peiyong Zhai
    Junichi Sadoshima
    Journal of Cardiovascular Translational Research, 2010, 3 : 304 - 313
  • [4] Cardiac apoptosis in the transition from left ventricular hypertrophy to left ventricular dysfunction in rats with chronic pressure overload
    Morisco, C
    Monti, F
    Condorelli, G
    Notte, A
    deRienzo, A
    Lembo, G
    Trimarco, B
    CIRCULATION, 1997, 96 (08) : 4177 - 4177
  • [5] Interstitial expansion in pressure overload left ventricular hypertrophy
    Thomas A Treibel
    Steven K White
    Daniel Sado
    Filip Zemrak
    Sanjay M Banypersad
    Andrew Flett
    Mark Caulfield
    Anna S Herrey
    Steffen E Petersen
    James Moon
    Journal of Cardiovascular Magnetic Resonance, 15 (Suppl 1)
  • [6] Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload
    Beetz, Nadine
    Rommel, Carolin
    Schnick, Tilman
    Neumann, Elena
    Lother, Achim
    Monroy-Ordonez, Elsa Beatriz
    Zeeb, Martin
    Preissl, Sebastian
    Gilsbach, Ralf
    Melchior-Becker, Ariane
    Rylski, Bartosz
    Stoll, Monika
    Schaefer, Liliana
    Beyersdorf, Friedhelm
    Stiller, Brigitte
    Hein, Lutz
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 101 : 145 - 155
  • [7] Melatonin Blunts Pressure-overload Left Ventricular Hypertrophy and Improves Cardiac Performance in Pathologic and PPhysiologic Cardiac Hypertrophy
    Offerhaus, Joost
    Lee, Dong
    Bedja, Djahida
    Cingolani, Oscar
    CIRCULATION, 2015, 132
  • [8] Control aspects of left ventricular wall thickness in pressure overload left ventricular hypertrophy
    Feng, MJ
    Drzewiecki, GM
    Li, JKJ
    PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 2002, : 37 - 38
  • [9] LEFT-VENTRICULAR HYPERTROPHY DUE TO VOLUME OVERLOAD VERSUS PRESSURE OVERLOAD
    CARABELLO, BA
    ZILE, MR
    TANAKA, R
    COOPER, G
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04): : H1137 - H1144
  • [10] LEFT-VENTRICULAR FUNCTION IN HYPERTROPHY DUE TO PRESSURE OVERLOAD
    BROUGHTON, A
    KORNER, PI
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (03): : 390 - 391